Q2FY19 results were operationally in line with I-direct estimates. However, net profit was lower mainly due to lower other income and higher tax rate (33% vs. I-direct estimate of 21%) Revenues grew 12.9% YoY to | 2090 crore (I-direct estimate: | 2092.4 crore) on the back of 16.4% YoY growth in pharmacy...